Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Stocks Regain Late Form, Close Near Day's Highs as Greek Resolution Nears

Published 02/14/2012, 01:02 AM
Updated 07/09/2023, 06:31 AM
NDX
-
DJI
-
JP225
-
HK50
-
FLG
-
GC
-
CL
-
NG
-
NBGr
-
REGN
-
After-Hours: Closing Update: Stocks Regain Late Form, Close Near Day's Highs as Greek Resolution Nears

4:09 PM, Feb 13, 2012 -- Stocks posted solid, if unspectacular, gains today, bouncing back from Friday's declines after Greek lawmakers this weekend approved 325 billion euro in austerity measures that other Euro-zone members demanded in exchange for rescue funds needed to avoid a default on Greek sovereign debt. Commodities also finished higher.

Financial ministers from throughout the European Union still need to sign off on the austerity plan as well as voting to release a 145 billion euro bailout package. That decision is scheduled for Wednesday, possibly keeping a lid on gains for U.S. equities on Monday.

President Obama also today formally released his $3.8 trillion budget proposal for the federal government's fiscal year beginning in October. He proposed increased spending for education and re-training as well as infrastructure projects in a bid to increase job growth. The package also boosts taxes on wealthier Americans, including counting capital gains as earned income while reducing some corporate tax rates. Republicans rejected the plan almost immediately, and most Congressional observers expect little action on the FY13 budget until after the November elections in a lameduck session.

In company news, Apple (AAPL) traded on both sides of $500 a share today, hitting new all-time highs even as the tech giant confirmed it has asked the Fair Labor Association to conduct audits of its suppliers, including Foxconn Technology Group factories in Shenzhen and Chengdu, China.

Shares of Regeneron Pharmaceuticals Inc. (RGEN) rose sharply Monday after the company predicted much stronger sales of its eye drug Eylea. Q4 Eylea sales were $24.8 million and the company said it now expects $250 million to $300 million in U.S. sales in 2012, up from its previous forecast of $140 million to $160 million in sales.

National Bank of Greece (NGB) also rallied today, with ADRs rising up about 12% following the Greek parliament vote yesterday.

Commodities were mixed today. March gold settled at $1,723 an ounce, down 30 cents, after trading moderately higher during most of the day. Crude oil settled at $101.00 a barrel, gaining $2.33, according to preliminary CME data, although figures were delayed due to technical problems resulting in the crude complex re-opening at 3:15 p.m. ET with a 15-minute pre-open. The problem also disrupted settlements for natural gas futures.

Here's where markets stand at end-of-day:

Dow Jones Industrial Average up 72.81 (+0.57%) to 12,874.04.

S&P 500 up 9.13 (+0.68%) to 1,351.77.

Nasdaq up 27.51 (+0.95%) to 2,931.39

GLOBAL SENTIMENT

Nikkei up 0.58%.

Hang Seng up 0.50%.

Shanghai Composite down 0.01%.

FTSE-100 up 0.78%.

UPSIDE MOVERS

(+) DBD, Q4 profit tops Street; guides FY12 EPS $2.18 to $2.41, above analysts' $2.29.

(+) GNOM, Will provide whole human genome sequencing to Mayo Clinic.

DOWNSIDE MOVERS

(-) CHTP, FDA said to questioning clinical data for lead drug candidate ahead of vote later this month.

(-) CRD-B, Reports Q4 EPS of $0.03; Street expected $0.15 a share.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.